Pascal Girard

6PUBLICATIONS
15CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 08, 2025
Historical Use of Markov Model and Posterior Predictive Checks in Pharmacometrics.

Pascal Girard, Helen Kastrissios

|Aug 12, 2024
Model-informed Evidence for Clinical Non-inferiority of Every-2-Weeks Versus Standard Weekly Dosing Schedule of Cetuximab in Metastatic Colorectal Cancer.

Ana-Marija Milenković-Grišić, Siobhán Hayes, Colm Farrell

|Jun 17, 2023
Modeling tumor size dynamics based on real-world electronic health records and image data in advanced melanoma patients receiving immunotherapy.

Perrine Courlet, Daniel Abler, Monia Guidi

|May 05, 2023
Semiautomated Pipeline to Quantify Tumor Evolution From Real-World Positron Emission Tomography/Computed Tomography Imaging.

Daniel Abler, Perrine Courlet, Matthieu Dietz

|Jun 30, 2022
Exposure-response analyses for the MET inhibitor tepotinib including patients in the pivotal VISION trial: support for dosage recommendations.

Wenyuan Xiong, Sofia Friberg Hietala, Joakim Nyberg

|Apr 07, 2022
Population pharmacokinetic analysis of tepotinib, an oral MET kinase inhibitor, including data from the VISION study.

Wenyuan Xiong, Orestis Papasouliotis, E Niclas Jonsson

Pageof 1